Effects of basic carbohydrate counting versus standard dietary care for glycaemic control in type 2 diabetes (The BCC Study): a randomised, controlled trial

被引:1
|
作者
Ewers, Bettina [1 ]
Blond, Martin B. [1 ]
Bruun, Jens M. [2 ,3 ]
Vilsboll, Tina [1 ,4 ]
机构
[1] Steno Diabet Ctr Copenhagen, Dept Clin & Translat Res, Herlev, Denmark
[2] Steno Diabet Ctr Aarhus, Aarhus, Denmark
[3] Univ Aarhus, Dept Clin Med, Aarhus, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
来源
NUTRITION & DIABETES | 2024年 / 14卷 / 01期
关键词
NUTRITION THERAPY; MANAGEMENT; RECOMMENDATIONS; INDIVIDUALS; VALIDATION; LITERACY; NUMERACY; ADULTS;
D O I
10.1038/s41387-024-00307-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Clinical guidelines recommend basic carbohydrate counting (BCC), or similar methods to improve carbohydrate estimation skills and to strive for higher consistency in carbohydrate intake potentially improving glycaemic control. However, evidence for this approach in type 2 diabetes (T2D) is limited. Objective: To examine the efficacy of a structured education program in BCC as add-on to standard dietary care on glycaemic control in individuals with T2D. Methods: The BCC Study was a randomized, controlled, open-label, parallel-group trial. Individuals with T2D aged 18-75 years with glycated haemoglobin A1c (HbA1c) 53-97 mmol/mol (7.0-11.0%) were randomly assigned (1:1) to BCC or standard dietary care. The primary outcomes were differences in changes in HbA1c or glycaemic variability (calculated as mean amplitude of glycaemic excursions [MAGE]) between groups after six months of intervention. Results: Between September 2018 and July 2021, 48 participants were randomly assigned, 23 to BCC and 25 to standard dietary care. Seven participants did not receive the allocated intervention. From a baseline-adjusted mean of 65 mmol/mol (95% CI 62-68 [8.1%, 7.8-8.4]), HbA1c changed by -5 mmol/mol (-8 to -1 [-0.5%, -0.7 to -0.1]) in BCC and -3 mmol/mol (-7 to 1 [-0.3%, -0.6 to 0.1]) in standard care with an estimated treatment effect of -2 mmol/mol (-7 to 4 [-0.2%, -0.6 to 0.4]); p = 0.554. From a baseline-adjusted mean of 4.2 mmol/l (3.7 to 4.8), MAGE changed by -16% (-33 to 5) in BCC and by -3% (-21 to 20) in standard care with an estimated treatment effect of -14% (-36 to 16); p = 0.319. Only median carbohydrate estimation error in favour of BCC (estimated treatment difference -55% (-70 to -32); p < 0.001) remained significant after multiple testing adjustment. Conclusions: No glycaemic effects were found but incorporating BCC as a supplementary component to standard dietary care led to improved skills in estimating carbohydrate intake among individuals with T2D.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial
    Domenico Tricò
    Maria Chiara Masoni
    Simona Baldi
    Noemi Cimbalo
    Luca Sacchetta
    Maria Tiziana Scozzaro
    Giulia Nesti
    Alessandro Mengozzi
    Lorenzo Nesti
    Martina Chiriacò
    Andrea Natali
    Diabetologia, 2024, 67 : 263 - 274
  • [32] Effects of Carbohydrate Restriction on Body Weight and Glycemic Control in Individuals with Type 2 Diabetes: A Randomized Controlled Trial of Efficacy in Real-Life Settings
    Weber, Philip
    Thomsen, Mads N. N.
    Skytte, Mads Juul
    Samkani, Amirsalar
    Carl, Martin Hansen
    Astrup, Arne
    Frystyk, Jan
    Holst, Jens J. J.
    Hartmann, Bolette
    Madsbad, Sten
    Magkos, Faidon
    Krarup, Thure
    Haugaard, Steen B. B.
    NUTRIENTS, 2022, 14 (24)
  • [33] Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial
    Trico, Domenico
    Masoni, Maria Chiara
    Baldi, Simona
    Cimbalo, Noemi
    Sacchetta, Luca
    Scozzaro, Maria Tiziana
    Nesti, Giulia
    Mengozzi, Alessandro
    Nesti, Lorenzo
    Chiriaco, Martina
    Natali, Andrea
    DIABETOLOGIA, 2024, 67 (02) : 263 - 274
  • [34] Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial
    Gallwitz, Baptist
    Guzman, Juan
    Dotta, Francesco
    Guerci, Bruno
    Simo, Rafael
    Basson, Bruce R.
    Festa, Andreas
    Kiljanski, Jacek
    Sapin, Helene
    Trautmann, Michael
    Schernthaner, Guntram
    LANCET, 2012, 379 (9833) : 2270 - 2278
  • [35] Dietary calcium from dairy, body composition and glycaemic control in patients with type 2 diabetes pursuing an energy restricted diet: A parallel group randomised clinical trial
    Geraldo Gomes, Junia Maria
    Costa, Jorge de Assis
    Goncalves Alfenas, Rita De Cassia
    INTERNATIONAL DAIRY JOURNAL, 2017, 73 : 50 - 56
  • [36] The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial
    Welschen, Laura M. C.
    Bot, Sandra D. M.
    Dekker, Jacqueline M.
    Timmermans, Danielle R. M.
    van der Weijden, Trudy
    Nijpels, Giel
    BMC PUBLIC HEALTH, 2010, 10
  • [37] Randomised-controlled trial of a web-based dietary intervention for patients with type 2 diabetes: changes in health cognitions and glycemic control
    Ramadas, Amutha
    Chan, Carina Ka Yee
    Oldenburg, Brian
    Hussein, Zanariah
    Quek, Kia Fatt
    BMC PUBLIC HEALTH, 2018, 18
  • [38] A multicomponent health care intervention is associated with improved glycaemic control in subjects with poorly controlled type 2 diabetes compared with routine care: The INTEGRA study
    Mollo, Angels
    Vlacho, Bogdan
    Gratacos, Monica
    Mata-Cases, Manel
    Rubinat, Esther
    Berenguera Osso, Anna
    Cos, Francesc Xavier
    Franch-Nadal, Josep
    Khunti, Kamlesh
    Mauricio, Didac
    DIABETES OBESITY & METABOLISM, 2023, 25 (12) : 3549 - 3559
  • [39] The effect of basic carbohydrate counting on HbA1c in type 2 diabetic patients: A non-randomized controlled trial
    Vural, Hamide
    Uzuner, Arzu
    Unalan, Pemra C.
    Sinav, Hayal Ozkan
    PRIMARY CARE DIABETES, 2023, 17 (06) : 625 - 631
  • [40] Randomised-controlled trial of a web-based dietary intervention for patients with type 2 diabetes mellitus: Study protocol of myDIDeA
    Ramadas, Amutha
    Quek, Kia Fatt
    Chan, Carina K. Y.
    Oldenburg, Brian
    Hussein, Zanariah
    BMC PUBLIC HEALTH, 2011, 11